Elan Corp. AI Stock Analysis
Want to see JP:6099 full AI Analyst Report?
Elan Corp. (6099) AI Stock Analysis
Elan Corp.
(TSE/TYO:6099)
Strong financial stability from minimal debt and healthy cash flows, along with bullish technical signals from price trends and momentum indicators, are the key drivers of the score. Reasonable valuation adds further support.
Elan Corp. (6099) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 45.65B
- Dividend Yield
- 1.99%
- Average Volume (3M)
- 93.80K
- Price to Earnings (P/E)
- 13.4
- Beta (1Y)
- 0.28
- Revenue Growth
- 11.87%
- EPS Growth
- 37.37%
- Country
- Japan
- Employees
- 974
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Elan Corp. Business Overview & Revenue Model
Company Description
Elan Corporation operates within the healthcare sector, specializing in nursing and medical services. The company offers a rental and laundry service for crucial daily items such as clothing, towels, and diapers, primarily catering to patients in hos...
How the Company Makes Money
null
Elan Corp. Financial Statement Overview
Summary
Strong balance sheet with minimal debt and healthy cash flow generation, supported by consistent revenue growth, though minor profitability margin concerns exist.
Income Statement
75PositiveBalance Sheet
85Very PositiveCash Flow
80Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.78B | 55.45B | 47.51B | 41.43B | 36.26B | 31.64B |
| Gross Profit | 12.28B | 11.87B | 10.72B | 9.75B | 9.03B | 7.88B |
| EBITDA | 5.64B | 5.59B | 4.49B | 3.85B | 3.53B | 2.92B |
| Net Income | 2.92B | 2.77B | 2.35B | 2.52B | 2.08B | 1.91B |
Balance Sheet | ||||||
| Total Assets | 25.76B | 26.23B | 21.61B | 18.99B | 16.07B | 13.95B |
| Cash, Cash Equivalents and Short-Term Investments | 5.63B | 6.85B | 6.85B | 5.49B | 6.04B | 5.63B |
| Total Debt | 685.20M | 765.20M | 86.57M | 0 | 0 | 0 |
| Total Liabilities | 10.83B | 11.55B | 9.10B | 8.18B | 7.08B | 6.46B |
| Stockholders Equity | 14.52B | 14.44B | 12.50B | 10.81B | 8.99B | 7.48B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.18B | 3.62B | 1.59B | 1.23B | 2.03B |
| Operating Cash Flow | 0 | 4.29B | 4.50B | 1.78B | 1.58B | 2.11B |
| Investing Cash Flow | 0 | -3.39B | -2.23B | -1.66B | -624.51M | -357.68M |
| Financing Cash Flow | 0 | -906.86M | -849.53M | -667.09M | -552.96M | -614.15M |
Elan Corp. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6099, the sentiment is Positive. The current price of 755.00 is below the 20-day moving average (MA) of 755.45, above the 50-day MA of 733.54, and above the 200-day MA of 733.01, indicating a neutral trend. The MACD of 11.62 indicates Positive momentum. The RSI at 50.58 is Neutral, neither overbought nor oversold. The STOCH value of 25.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6099.
Elan Corp. Peers Comparison
Overall Rating
JP:609980Outperform
JP:606273Outperform
JP:237357Neutral
JP:242555Neutral
JP:706149Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | JPY 45.65B | 13.37 | 23.06% | 1.99% | 11.87% | 37.37% | |
| 73Outperform | JPY 64.04B | 14.44 | ― | 2.19% | 5.50% | 45.42% | |
| 57Neutral | JPY 5.18B | 18.02 | ― | 4.42% | 4.76% | -52.55% | |
| 55Neutral | JPY 2.50B | 28.24 | ― | 3.34% | -3.64% | -66.52% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | JPY 3.03B | -28.40 | ― | ― | 6.75% | -119.69% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6099 | Elan Corp. | 755.00 | 45.64 | 6.43% | |
| JP:2373 | Care Twentyone Corporation | 385.00 | -50.94 | -11.69% | |
| JP:2425 | Care Service Co., Ltd. | 658.00 | -115.78 | -14.96% | |
| JP:6062 | Charm Care Corporation | 1964.00 | 727.36 | 58.82% | |
| JP:7061 | Japan Hospice Holdings Inc. | 357.00 | -924.94 | -72.15% |
Elan Corp. Corporate Events
Elan Finalizes Terms for 12,000-Share Employee Stock Option Plan
Elan Corporation, listed on the Tokyo Stock Exchange’s Prime Market, announced the finalized terms of stock compensation-type share acquisition rights for company employees and directors and executive officers of subsidiaries. The program covers 120...
Elan Corp. Details Disaster-Relief Efforts After Kumamoto Earthquake
Elan Corp. operates in the support services sector, focusing on providing logistical assistance and relief-related supplies in times of emergency. The company leverages group-wide capabilities to deliver essential goods, such as drinking water, to af...
Elan Corp. lifts profits and reaffirms growth outlook for 2026
Elan Corporation reported solid growth for the nine months ended September 30, 2026, with net sales rising 10.5% year on year to ¥45.0 billion and operating profit climbing 31.2% to ¥4.0 billion. Net profit attributable to owners of the parent increa...
Elan Corp Boosts Stock Benefit Trust With New Share Acquisition Plan
Elan Corporation has approved an additional monetary contribution to its existing Stock Benefit Trust (J-ESOP), continuing an equity-based incentive plan for employees and executives. The new funding, totaling JPY 97,350,000, will be used by the trus...
Elan Launches Stock Compensation Options for Employees and Subsidiary Executives
Elan Corporation’s board has approved the issuance of its 5th Series share acquisition rights as stock compensation-type stock options to selected employees and subsidiary management. The program is designed to align management and staff with shareho...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
